Related Tags >> kidney cancer FDA safety profile biopharmaceutical company

renal cell carcinoma News

Most Popular renal cell carcinoma Story

Press Release: AVEO Acquires Clinical Stage Anti-Cancer Compound From Kirin

January 4, 2007 — 11:46am ET | By Maureen Martino

Press Release: AVEO Acquires Clinical Stage Anti-Cancer Compound From Kirin

Read more...

renal cell carcinoma Press Releases

Argos Therapeutics Announces New Data Demonstrating Prolonged Overall Survival in a Phase 2 Study of its Arcelis™ Immunotherapy
FDA Advisory Committee Finds The Benefit/Risk Profile Of Axitinib In Previously Treated Advanced Renal Cell Carcinoma (RCC
Astellas Pharma Europe Ltd Wins Scrip Award for Licensing Deal of the Year
Rexahn Pharmaceuticals Completes Patient Enrollment for Archexin Phase II Clinical Trial in Metastatic Pancreatic Cancer
Two Metabolon Studies Provide Insight into Kidney Cancer for University of California Davis

Latest Headlines

Argos garners $35.2M in third round
April 23, 2008
Press Release: AVEO Acquires Clinical Stage Anti-Cancer Compound From Kirin
January 4, 2007
ALSO NOTED: Aldagen raises venture funds; Thrombin submitted to FDA;and much more...
December 18, 2006
ALSO NOTED: Depomed surges on new data; FDA OKs Biomira study; and much more...
December 11, 2006
Bayer, Onyx announce disappointing Nexavar results
December 3, 2006
ALSO NOTED: Wyeth looking for Torisel approvals; Nanogen streamlines;and much more...
October 5, 2006
ALSO NOTED: FDA fast tracks Nexavar; ImClone, Merck KGaA amend pact; and much more...
July 19, 2006
FDA approves Nexavar for kidney cancer
December 20, 2005
ALSO NOTED: Safeguard acquires Acsis for $26M; Biogen issues 'Dear Doctor' letter; and much more...
November 10, 2005
BioMedica touts mid-stage Trovax trial data
October 5, 2005
Pfizer files NDA for Sutent
August 9, 2005

Paid Research Reports

More Research Reports >>